Aquestive Therapeutics, Inc. - stock earnings
AQST Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 7, 2024 AfterMarket | - / -0.0840000000 | - | - / 12.5 million | - |
AQST Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -8.1 million USD | 13.2 million USD |
| 2023Q3 | -2.0 million USD | 13.0 million USD |
| 2023Q2 | -5.8 million USD | 13.2 million USD |
| 2023Q1 | 19.3 million USD | 11.1 million USD |
| 2022Q4 | -18.1 million USD | 10.7 million USD |
| 2022Q3 | -16.2 million USD | 11.5 million USD |
| 2022Q2 | -19.8 million USD | 13.3 million USD |
| 2022Q1 | -16.7 million USD | 12.3 million USD |
| 2021Q4 | -28.9 million USD | 11.1 million USD |
| 2021Q3 | -14.6 million USD | 13.3 million USD |
| 2021Q2 | -12.4 million USD | 15.3 million USD |
| 2021Q1 | -14.7 million USD | 11.1 million USD |
| 2020Q4 | -20.4 million USD | 7.1 million USD |
| 2020Q3 | -16.6 million USD | 8.3 million USD |
| 2020Q2 | -2.3 million USD | 21.7 million USD |
| 2020Q1 | -16.5 million USD | 8.8 million USD |
| 2019Q4 | -12.6 million USD | 16.4 million USD |
| 2019Q3 | -18.4 million USD | 12.4 million USD |
| 2019Q2 | -20.5 million USD | 11.1 million USD |
| 2019Q1 | -14.7 million USD | 12.6 million USD |
| 2018Q4 | -13.9 million USD | 16.8 million USD |
| 2018Q3 | -15.0 million USD | 13.3 million USD |
| 2018Q2 | -36.5 million USD | 13.9 million USD |
| 2018Q1 | 4.1 million USD | 23.4 million USD |
| 2017Q4 | -10.0 million USD | 12.2 million USD |
| 2017Q3 | 8.5 million USD | 27.1 million USD |
| 2017Q2 | -5.9 million USD | 11.1 million USD |
| 2017Q1 | -1.5 million USD | 16.4 million USD |
| 2016Q4 | -11.9 million USD | 51.8 million USD |
| 2007Q2 | -3.9 million USD | 1.7 million USD |
| 2007Q1 | -4.0 million USD | 509000 USD |
AQST Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -7.9 million USD | 50.6 million USD |
| 2022 | -60.2 million USD | 47.7 million USD |
| 2021 | -90.0 million USD | 50.8 million USD |
| 2020 | -65.4 million USD | 45.8 million USD |
| 2019 | -72.7 million USD | 52.6 million USD |
| 2018 | -61.4 million USD | 67.4 million USD |
| 2017 | -8.9 million USD | 66.9 million USD |
| 2016 | -9.6 million USD | 51.8 million USD |
| 2006 | -12.8 million USD | 2.7 million USD |
| 2005 | -8.3 million USD | 2.1 million USD |
AQST
Price: $3.50
52 week price:
Earnings Per Share: -0.13 USD
P/E Ratio: -11.95
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 208846
Market Capitalization: 351.8 million